Tsveta Milanova, Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 2,868 shares at $28.96 ($83K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Scheduled sale ($83k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.96 | 1,187 | $34K | 41.4% |
| 2 | $28.96 | 1,681 | $49K | 58.6% |
| Total | $28.96 avg | 2,868 | $83K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $186K | — | Filing → |
| AGIO | SELL | 2025-03-04 | $119K | — | Filing → |